ZBIO Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 5 hours ago Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $1.39 per share, a wider loss than the -$1.19 estimate…